Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAkşit, Dilek
dc.contributor.authorKorkut, Oğuzhan
dc.contributor.authorAksöz, Elif
dc.contributor.authorGökbulut, Cengiz
dc.date.accessioned2019-10-17T11:08:17Z
dc.date.available2019-10-17T11:08:17Z
dc.date.issued2016en_US
dc.identifier.issn0048-0169
dc.identifier.issn1176-0710
dc.identifier.urihttps://doi.org/ 10.1080/00480169.2016.1146172
dc.identifier.urihttps://hdl.handle.net/20.500.12462/8459
dc.description.abstractAIMS: To investigate the plasma disposition and faecal excretion of eprinomectin (EPM) in non-lactating dairy cattle following topical and S/C administration.METHODS: Holstein dairy cows, 3.5-5 years-old, were selected 20-25 days after being dried off and were randomly allocated to receive EPM either topically (n=5) or S/C (n=5) at dose rates of 0.5 and 0.2 mg/kg bodyweight, respectively. Heparinised blood and faecal samples were collected at various times between 1 hour and 30 days after treatment, and were analysed for concentrations of EPM using high performance liquid chromatography with a fluorescence detector. RESULTS: The maximum concentration of EPM in plasma (C-max) and the time to reach C-max were both greater after S/C administration (59.70 (SD 12.90) ng/mL and 1.30 (SD 0.27) days, respectively) than after topical administration (20.73 (SD 4.04) ng/mL and 4.40 (SD 0.89) days, respectively) (p<0.001). In addition, S/C administration resulted in greater plasma availability (area under the curve; AUC), and a shorter terminal half-life and mean residence time (295.9 (SD 61.47) ng. day/mL; 2.95 (SD 0.74) days and 4.69 (SD 1.01) days, respectively) compared with topical administration (168.2 (SD15.67) ng. day/mL; 4.63 (SD 0.32) days, and 8.23 (SD 0.57) days, respectively) (p<0.01). EPM was detected in faeces between 0.80 (SD 0.45) and 13.6 (SD 4.16) days following S/C administration, and between 1 (SD 0.5) and 20.0 (SD 3.54) days following topical administration. Subcutaneous administration resulted in greater faecal excretion than topical administration, expressed as AUC adjusted for dose (1188.9 (SD 491.64) vs. 311.5 (SD 46.90) ng. day/g; p<0.05). Maximum concentration in faeces was also higher following S/C than topical administration (223.0 (SD 63.96) vs. 99.47 (SD 43.24) ng/g; p<0.01). CONCLUSIONS: Subcutaneous administration of EPM generated higher plasma concentrations and greater plasma availability compared with topical administration in non-lactating cattle. Although the S/C route provides higher faecal concentrations, the longer faecal persistence of EPM following topical administration may result in more persistent efficacy preventing establishment of incoming nematode larvae in cattle.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.isversionof10.1080/00480169.2016.1146172en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectEprinomectinen_US
dc.subjectMacrocyclic Lactonesen_US
dc.subjectPharmacokineticsen_US
dc.subjectPour-Onen_US
dc.subjectDairy Cattleen_US
dc.subjectFaecesen_US
dc.subjectEcotoxicien_US
dc.titlePlasma disposition and faecal excretion of eprinomectin following topical and subcutaneous administration in non-lactating dairy cattleen_US
dc.typearticleen_US
dc.relation.journalNew Zealand Veterınary Journalen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorIDhttp://orcid.org/0000-0002-4912-7307en_US
dc.contributor.authorID0000-0001-6595-7821en_US
dc.identifier.volume64en_US
dc.identifier.issue4en_US
dc.identifier.startpage207en_US
dc.identifier.endpage211en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster